Latest News and Press Releases

BOSTON und DURHAM, N.C., July 06, 2021 (GLOBE NEWSWIRE) -- Parexel, ein weltweit führendes Auftragsforschungsinstitut (CRO), das sich auf die Entwicklung und Bereitstellung innovativer neuer...

BOSTON e DURHAM, N.C., July 06, 2021 (GLOBE NEWSWIRE) -- A Parexel, principal organização global de pesquisa clínica (clinical research organization - CRO) focada no desenvolvimento e entrega de...

BOSTON dan DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, sebuah organisasi penyelidikan klinikal global (CRO) terkemuka yang berfokus pada pembangunan dan penyampaian terapi baharu yang...

보스턴, 노스캐롤라이나주 더럼, July 07, 2021 (GLOBE NEWSWIRE) -- 환자 건강 증진을 위한 혁신적인 신약 개발 및 공급에 중점을 두고 있는 글로벌 CRO(임상시험수탁기관)인 Parexel은 EQT IX 펀드(“EQT Private Equity”)와 Goldman Sachs Asset Management...

BOSTON et DURHAM, Caroline du Nord, 06 juill. 2021 (GLOBE NEWSWIRE) -- Parexel, une organisation de recherche clinique (CRO) de premier plan à l'échelle mondiale axée sur le développement et la...

波士頓及北卡羅來納州達勒姆, July 07, 2021 (GLOBE NEWSWIRE) -- Parexel 是一家領先的全球臨床研究組織，專注開發和提供創新的新療法以促進患者健康，今天宣佈執行最終合併協議，公司將被 EQT IX 基金（「EQT Private Equity」）以及 Pamplona Capital Management LP 旗下的 Goldman Sachs...

BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...

BOSTON and DURHAM, N.C., May 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth...

BOSTON and DURHAM, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...

BOSTON and Durham, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...